Acquired in-process research and development expenses
Vertex Pharmaceuticals·Business Segments·1 segment·Rolls up to Acquired in-process research and development
Breakdown
Segments
Business SegmentsView metric
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Business Segments | $19.8M | $2.2M | $54.5M | $56.5M | $500K |
| Total | $19.8M | $2.2M | $54.5M | $56.5M | — |